Concepedia

Considerations on implementing diagnostic markers into clinical decision making in bladder cancer

Yair Lotan, Shahrokh F. Shariat, Bernd J. Schmitz‐Dräger, Marta Sänchez‐Carbayo, Feliksas Jankevičius, Marco Racioppi, Sarah Minner, Brigitte Stöhr, Pier Francesco Bassi, H. Barton Grossman

Urologic Oncology Seminars and Original Investigations · 2010 · 106 citations · 44 references

DOI

Concepts

References

44

Screening and Prostate-Cancer Mortality in a Randomized European Study

Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol et al. · New England Journal of Medicine · 2009 · 4K citations · Full text

, , +14

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 3K citations

, , +10

Mortality Results from a Randomized Prostate-Cancer Screening Trial

Gerald L. Andriole, E. David Crawford, Robert L. Grubb et al. · New England Journal of Medicine · 2009 · 2.9K citations · Full text

, , +12

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · JNCI Journal of the National Cancer Institute · 2005 · 2.1K citations · Full text

, , +16

REporting recommendations for tumor MARKer prognostic studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · Nature Clinical Practice Oncology · 2005 · 562 citations

, , +16